Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

Science 302 (5648): 1215-1217

Copyright © 2003 by the American Association for the Advancement of Science

Nonsteroidal Anti-Inflammatory Drugs Can Lower Amyloidogenic Aß42 by Inhibiting Rho

Yan Zhou,* Yuan Su, Baolin Li, Feng Liu, John W. Ryder, Xin Wu, Patricia A. Gonzalez-DeWhitt, Valentina Gelfanova, John E. Hale, Patrick C. May, Steven M. Paul,* Binhui Ni

Abstract: A subset of nonsteroidal anti-inflammatory drugs (NSAIDs) has been shown to preferentially reduce the secretion of the highly amyloidogenic, 42-residue amyloid-ß peptide Aß42. We found that Rho and its effector, Rho-associated kinase, preferentially regulated the amount of Aß42 produced in vitro and that only those NSAIDs effective as Rho inhibitors lowered Aß42. Administration of Y-27632, a selective Rock inhibitor, also preferentially lowered brain levels of Aß42 in a transgenic mouse model of Alzheimer's disease. Thus, the Rho-Rock pathway may regulate amyloid precursor protein processing, and a subset of NSAIDs can reduce Aß42 through inhibition of Rho activity.

Neuroscience Discovery Research and Bioresearch Technologies and Proteins, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA.

* To whom correspondence should be addressed. E-mail: paul_steven_m{at}lilly.com; zhou_yan_yz{at}lilly.com


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Farnesyltransferase Haplodeficiency Reduces Neuropathology and Rescues Cognitive Function in a Mouse Model of Alzheimer Disease.
S. Cheng, D. Cao, D. A. Hottman, L. Yuan, M. O. Bergo, and L. Li (2013)
J. Biol. Chem. 288, 35952-35960
   Abstract »    Full Text »    PDF »
Pharmacologic Inhibition of ROCK2 Suppresses Amyloid-{beta} Production in an Alzheimer's Disease Mouse Model.
J. H. Herskowitz, Y. Feng, A. L. Mattheyses, C. M. Hales, L. A. Higginbotham, D. M. Duong, T. J. Montine, J. C. Troncoso, M. Thambisetty, N. T. Seyfried, et al. (2013)
J. Neurosci. 33, 19086-19098
   Abstract »    Full Text »    PDF »
Sorting receptor SORLA - a trafficking path to avoid Alzheimer disease.
T. E. Willnow and O. M. Andersen (2013)
J. Cell Sci. 126, 2751-2760
   Abstract »    Full Text »    PDF »
Rho Kinase II Phosphorylation of the Lipoprotein Receptor LR11/SORLA Alters Amyloid-{beta} Production.
J. H. Herskowitz, N. T. Seyfried, M. Gearing, R. A. Kahn, J. Peng, A. I. Levey, and J. J. Lah (2011)
J. Biol. Chem. 286, 6117-6127
   Abstract »    Full Text »    PDF »
The Protective Effect of Rho-Associated Kinase Inhibitor on Aluminum-Induced Neurotoxicity in Rat Cortical Neurons.
T.-J. Chen, H.-S. Hung, D.-C. Wang, and S.-S. Chen (2010)
Toxicol. Sci. 116, 264-272
   Abstract »    Full Text »    PDF »
Ibuprofen modifies cognitive disease progression in an Alzheimer's mouse model.
D. Van Dam, K. Coen, and P. De Deyn (2010)
J Psychopharmacol 24, 383-388
   Abstract »    PDF »
A Molecular Mechanism for Ibuprofen-Mediated RhoA Inhibition in Neurons.
J. Dill, A. R. Patel, X.-L. Yang, R. Bachoo, C. M. Powell, and S. Li (2010)
J. Neurosci. 30, 963-972
   Abstract »    Full Text »    PDF »
Inhibition of Rho Kinases Enhances the Degradation of Mutant Huntingtin.
P. O. Bauer, H. K. Wong, F. Oyama, A. Goswami, M. Okuno, Y. Kino, H. Miyazaki, and N. Nukina (2009)
J. Biol. Chem. 284, 13153-13164
   Abstract »    Full Text »    PDF »
Cyclooxygenase-2 inhibition improves amyloid-{beta}-mediated suppression of memory and synaptic plasticity.
L. A. Kotilinek, M. A. Westerman, Q. Wang, K. Panizzon, G. P. Lim, A. Simonyi, S. Lesne, A. Falinska, L. H. Younkin, S. G. Younkin, et al. (2008)
Brain 131, 651-664
   Abstract »    Full Text »    PDF »
Geranylgeranyl pyrophosphate stimulates {gamma}-secretase to increase the generation of A and APP-CTF{gamma}.
Y. Zhou, A. Suram, C. Venugopal, A. Prakasam, S. Lin, Y. Su, B. Li, S. M. Paul, and K. Sambamurti (2008)
FASEB J 22, 47-54
   Abstract »    Full Text »    PDF »
Neuroglobin attenuates -amyloid neurotoxicity in vitro and transgenic Alzheimer phenotype in vivo.
A. A. Khan, X. O. Mao, S. Banwait, K. Jin, and D. A. Greenberg (2007)
PNAS 104, 19114-19119
   Abstract »    Full Text »    PDF »
Statins Reduce Amyloid-beta Production through Inhibition of Protein Isoprenylation.
S. M. Ostrowski, B. L. Wilkinson, T. E. Golde, and G. Landreth (2007)
J. Biol. Chem. 282, 26832-26844
   Abstract »    Full Text »    PDF »
Nonsteroidal Anti-Inflammatory Drugs Promote Axon Regeneration via RhoA Inhibition.
Q. Fu, J. Hue, and S. Li (2007)
J. Neurosci. 27, 4154-4164
   Abstract »    Full Text »    PDF »
Regulation of airway smooth muscle RhoA/ROCK activities by cholinergic and bronchodilator stimuli.
C. Liu, J. Zuo, and L. J. Janssen (2006)
Eur. Respir. J. 28, 703-711
   Abstract »    Full Text »    PDF »
beta-Amyloid infusion results in delayed and age-dependent learning deficits without role of inflammation or beta-amyloid deposits.
T. Malm, M. Ort, L. Tahtivaara, N. Jukarainen, G. Goldsteins, J. Puolivali, A. Nurmi, R. Pussinen, T. Ahtoniemi, T.-K. Miettinen, et al. (2006)
PNAS 103, 8852-8857
   Abstract »    Full Text »    PDF »
Rac GTPase signaling through the PP5 protein phosphatase.
S. Gentile, T. Darden, C. Erxleben, C. Romeo, A. Russo, N. Martin, S. Rossie, and D. L. Armstrong (2006)
PNAS 103, 5202-5206
   Abstract »    Full Text »    PDF »
RAC1 Inhibition Targets Amyloid Precursor Protein Processing by {gamma}-Secretase and Decreases A{beta} Production in Vitro and in Vivo.
L. Desire, J. Bourdin, N. Loiseau, H. Peillon, V. Picard, C. De Oliveira, F. Bachelot, B. Leblond, T. Taverne, E. Beausoleil, et al. (2005)
J. Biol. Chem. 280, 37516-37525
   Abstract »    Full Text »    PDF »
Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs.
K. P. Townsend and D. Pratico (2005)
FASEB J 19, 1592-1601
   Abstract »    Full Text »    PDF »
Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer's Disease.
M. Kitazawa, S. Oddo, T. R. Yamasaki, K. N. Green, and F. M. LaFerla (2005)
J. Neurosci. 25, 8843-8853
   Abstract »    Full Text »    PDF »
Compounds That Bind APP and Inhibit A{beta} Processing in Vitro Suggest a Novel Approach to Alzheimer Disease Therapeutics.
A. S. Espeseth, M. Xu, Q. Huang, C. A. Coburn, K. L. G. Jones, M. Ferrer, P. D. Zuck, B. Strulovici, E. A. Price, G. Wu, et al. (2005)
J. Biol. Chem. 280, 17792-17797
   Abstract »    Full Text »    PDF »
3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors Attenuate {beta}-Amyloid-Induced Microglial Inflammatory Responses.
A. Cordle and G. Landreth (2005)
J. Neurosci. 25, 299-307
   Abstract »    Full Text »    PDF »
Lack of Specific Amyloid-{beta}(1-42) Suppression by Nonsteroidal Anti-Inflammatory Drugs in Young, Plaque-Free Tg2576 Mice and in Guinea Pig Neuronal Cultures.
T. A. Lanz, G. J. Fici, and K. M. Merchant (2005)
J. Pharmacol. Exp. Ther. 312, 399-406
   Abstract »    Full Text »    PDF »
Selected Non-steroidal Anti-inflammatory Drugs and Their Derivatives Target {gamma}-Secretase at a Novel Site: EVIDENCE FOR AN ALLOSTERIC MECHANISM.
D. Beher, E. E. Clarke, J. D. J. Wrigley, A. C. L. Martin, A. Nadin, I. Churcher, and M. S. Shearman (2004)
J. Biol. Chem. 279, 43419-43426
   Abstract »    Full Text »    PDF »
Brain Inflammation and Alzheimer's-Like Pathology in Individuals Exposed to Severe Air Pollution.
L. Calderon-Garciduenas, W. Reed, R. R. Maronpot, C. Henriquez-Roldan, R. Delgado-Chavez, A. Calderon-Garciduenas, I. Dragustinovis, M. Franco-Lira, M. Aragon-Flores, A. C. Solt, et al. (2004)
Toxicol Pathol 32, 650-658
   Abstract »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882